Role of c-MYC in tumor-associated macrophages and cancer progression

Transcription factors of the MYC family regulate several homeostatic cell functions, and their role as proto-oncogenes has been the focus of interest for decades. We have recently demonstrated that c-MYC is expressed by tumor-associated macrophages (TAMs) and regulates their phenotype and pro-tumor activities in vivo.

• Publication year

  2013

• Venue

  Oncoimmunology

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/onci.22984PMID 23526468PMCID 3601167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities

  2012cited by this paper
• Differentiation and gene expression profile of tumor-associated macrophages.

  2012cited by this paper
• Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.

  2012cited by this paper
• Protective and pathogenic functions of macrophage subsets

  2011cited by this paper
• Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

  2010cited by this paper
• Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

  2009cited by this paper
• Is cell competition relevant to cancer?

  2008cited by this paper
• Cell competition and its possible relation to cancer.

  2008cited by this paper
• Distinct role of macrophages in different tumor microenvironments.

  2006cited by this paper
• dMyc transforms cells into super-competitors.

  2004cited by this paper

• Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy

  2025cites this paper
• The Role of MYC in Tumor Immune Microenvironment Regulation: Insights and Future Directions.

  2025cites this paper
• Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages

  2025cites this paper
• Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy

  2024cites this paper
• Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance

  2023cites this paper
• The Roles of Tumor-Associated Macrophages in Prostate Cancer

  2022cites this paper
• Tumor-associated macrophages in lymphoma: From mechanisms to therapy.

  2022cites this paper
• MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.

  2021cites this paper
• Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapy.

  2021cites this paper
• miR-193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma

  2020cites this paper
• MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis

  2020cites this paper
• Macrophage Origin, Metabolic Reprogramming and IL-1β Signaling: Promises and Pitfalls in Lung Cancer

  2019cites this paper
• Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors

  2018cites this paper
• Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages.

  2017cites this paper
• Secondary Alterations of Hepatocellular Carcinoma

  2016cites this paper
• Macrophages, Inflammation, and Lung Cancer.

  2016cites this paper
• Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.

  2016cites this paper
• The progress of angiogenic factors in the development of leukemias.

  2016cites this paper
• A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression

  2015cites this paper
• Trial Watch: Proteasomal inhibitors for anticancer therapy

  2014cites this paper
• Experimental research of host macrophage canceration induced by glioma stem progenitor cells

  2014cites this paper
• The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma

  2014cites this paper
• Inhibition of MYC in macrophages: tumor vs inflammation-related diseases

  2014cites this paper